Owens & Minor, Inc. (NYSE:OMI) Receives $6.35 Average Price Target from Analysts

Owens & Minor, Inc. (NYSE:OMI) has been assigned a consensus recommendation of “Reduce” from the seven ratings firms that are presently covering the firm, MarketBeat.com reports. Four equities research analysts have rated the stock with a sell rating and three have issued a buy rating on the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $6.35.

OMI has been the subject of a number of research analyst reports. Zacks Research lowered shares of Owens & Minor from a “hold” rating to a “strong sell” rating in a research note on Monday, November 10th. Weiss Ratings restated a “sell (e+)” rating on shares of Owens & Minor in a research report on Wednesday, October 8th.

Owens & Minor Price Performance

Owens & Minor has a 52 week low of $2.38 and a 52 week high of $15.54. The company has a 50 day moving average of $2.82 and a 200-day moving average of $4.36. The firm has a market capitalization of $223.92 million, a PE ratio of -0.17 and a beta of 1.37.

Owens & Minor (NYSE:OMI) last issued its quarterly earnings results on Thursday, October 30th. The company reported $0.25 EPS for the quarter, beating analysts’ consensus estimates of $0.23 by $0.02. Owens & Minor had a positive return on equity of 95.57% and a negative net margin of 19.99%.The company had revenue of $697.26 million for the quarter, compared to analyst estimates of $704.06 million. During the same period last year, the company earned $0.36 earnings per share. The company’s quarterly revenue was up 1.5% compared to the same quarter last year. Research analysts forecast that Owens & Minor will post 1.51 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. UBS Group AG grew its holdings in Owens & Minor by 39.5% during the fourth quarter. UBS Group AG now owns 828,494 shares of the company’s stock worth $2,320,000 after acquiring an additional 234,675 shares during the period. Milestone Asset Management LLC bought a new position in shares of Owens & Minor during the 4th quarter valued at about $34,000. Allspring Global Investments Holdings LLC grew its stake in shares of Owens & Minor by 10.0% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 86,722 shares of the company’s stock worth $243,000 after purchasing an additional 7,879 shares during the last quarter. SG Americas Securities LLC raised its holdings in shares of Owens & Minor by 18.3% in the 4th quarter. SG Americas Securities LLC now owns 74,566 shares of the company’s stock worth $209,000 after purchasing an additional 11,542 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC bought a new stake in shares of Owens & Minor in the 4th quarter worth approximately $31,000. Institutional investors own 98.04% of the company’s stock.

Owens & Minor Company Profile

Owens & Minor, Inc is a global healthcare solutions company specializing in the distribution of medical and surgical supplies, as well as supply chain management services. The company partners with healthcare providers, manufacturers and group purchasing organizations to deliver critical products and customized logistics solutions across the continuum of care. Its offerings range from standard medical-surgical products to specialized clinical devices, all supported by technology-driven inventory management and consulting services aimed at optimizing operational efficiency for hospitals, ambulatory surgery centers and other care facilities.

Founded in 1882 and headquartered in Mechanicsville, Virginia, Owens & Minor has evolved from a regional pharmaceutical distributor into a leader in healthcare logistics.